Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Receptor tyrosine kinase alterations in AML - biology and therapy.

Cancer treatment and research - 1 Jan 2010

Stirewalt Derek L, Meshinchi Soheil

Abstract excerpt

Acute myeloid leukemia (AML) is the most common form of leukemia in adults, and despite some recent progress in understanding the biology of the disease, AML remains the leading cause of leukemia-related deaths in adults and children. AML is a complex and heterogeneous disease, often involving mu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Delivery Systems
Share to fms-Like Tyrosine Kinase 3
Share to Forecasting

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Duplication

Share to Leukemia, Myeloid, Acute

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins c-kit

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 20306247
DOI: 10.1007/978-0-387-69259-3_6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20306247-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Receptor tyrosine kinase alterations in AML - biology and therapy.PMID 20306247Read ↗

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.Semantic proximity Read ↗

The molecular pathology of acute myeloid leukemia.Semantic proximity Read ↗

Molecular Analysis of Gene Rearrangements and Mutations in Acute Leukemias and Myeloid Neoplasms.Semantic proximity Read ↗

Mutations in AML: prognostic and therapeutic implications.Semantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectivesSemantic proximity Read ↗

Class III Receptor Tyrosine Kinases in Acute Leukemia – Biological Functions and Modern Laboratory AnalysisSemantic proximity Read ↗

Molecularly targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

Significance of oncogenes and tumor suppressor genes in AML prognosis.Semantic proximity Read ↗

Emerging therapies for acute myeloid leukemia: translating biology into the clinic.Semantic proximity Read ↗

New strategies to treat AML: novel insights into AML survival pathways and combination therapiesSemantic proximity Read ↗

Understanding the Molecular Basis of Acute Myeloid Leukemias: Where are we Now?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.